Latest Breaking News On - Trial exceeding original - Page 1 : comparemela.com

MALVERN, Pa., April 02, 2024 Annovis Bio, Inc. , a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, today provided a summary of corporate updates.

United statesAnnovis bioMaria maccecchiniAndrew walshMarial maccecchiniSecurities exchangePq corporationAnnovis bio incCompany annual report on formEuropean unionYour strategic missionInventiv healthPotters industriesLast patient visitFull enrollmentTrial exceeding original